Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)

in response to

FDA approves drug that reduces MACE in Diabetes patients (Forbes)

ledenfrog

posted on Jun 14, 2016 07:21AM

See my rather lengthy breakdown of Liraglutide (Victoza) as well as another GLP-1 receptor agonist and 2 SGLT2 inhibitors here. Agreed, the RRR in 3-point MACE that Liraglutide and Empagliflozin have achieved thus far are only 13% and 14%, respectively. We hope and expect RVX-208 to be much greater than this.